At the University of Chicago, scientists have developed an absolutely innovative, promising treatment for COVID-19 in the form of nanoparticles with the ability to trap SARS-CoV-2 viruses inside the body and use the body’s own immune system to kill them.
The “nanotraps” lure the virus by imitating the target cells infected by the virus. When the virus gets trapped by the nanotraps, it is then sequestered from other cells and targeted for destruction by the immune system.
Theoretically, these nanotraps could be used on different variants of the virus, resulting in a promising new way to suppress the virus in the future. The therapy is still in the early stages of testing, but the researchers believe that it could be administered through a nasal spray as a treatment for COVID-19.
The findings of the study were published in the journal Matter on April 19th, 2021.
Since the pandemic began, our research team has been developing this new way to treat COVID-19. We have done rigorous testing to prove that these nanotraps work, and we are excited about their potential.
Jun Huang, Assistant Professor, Pritzker School of Molecular Engineering
The study was led by Huang’s lab.
Designing the Perfect Trap
Led by postdoctoral scholar Min Chen and graduate student Jill Rosenberg, the researchers designed the nanotrap by analyzing the mechanism used by SARS-CoV-2 to bind to cells—a spike-like protein on its surface that attaches itself to the ACE2 receptor protein found on a human cell.
The nanoparticles are made of FDA-approved polymers and phospholipids with a diameter of about 500 nm—quite smaller than a cell. This implies that the nanotraps can reach more areas within the body and capture the virus more effectively.
To ensure the tiny particles appeared the same way they expected, the researchers collaborated with the lab of Associate Professor Bozhi Tian to employ electron microscopes to achieve a better look.
From our imaging, we saw a solid core and a lipid bilayer shell. That’s the essential part because it mimics the cell.
Bozhi Tian, Associate Professor, Department of Chemistry, University of Chicago
The safety of the system was tested by the researchers in a mouse model, and no toxicity was found. Then, the nanotraps were tested against a pseudovirus, which is a less potent model of a virus that does not replicate, in human lung cells in tissue culture plates. It was found that they totally blocked the entry of the pseudovirus into the cells.
As soon as the pseudovirus attached itself to the nanoparticle—which took about 10 minutes after injection during the tests—the nanoparticles used a molecule that summons the macrophages in the body to engulf and disintegrate the nanotrap.
In general, macrophages eat nanoparticles inside the body. However, the nanotrap molecule accelerates the process. It was found that the nanoparticles were cleared and disintegrated within 48 hours.
The nanoparticles were also with a pseudovirus in an ex vivo lung perfusion system—a pair of donated lungs maintained alive with a ventilator—and it was discovered that they totally blocked infection in the lungs.
Moreover, they collaborated with scientists at Argonne National Laboratory to test the nanotraps using a live virus (instead of a pseudovirus) in an in vitro system. Their system was found to inhibit the virus 10 times better than neutralizing antibodies or soluble ACE2 alone.
Image Credit: Chen and Rosenberg et al.
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]
In a recent study conducted at the Baylor College of Medicine, Houston, USA, scientists have identified six vaccine breakthrough cases caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A [...]
A new Covid-19 strain that is much more dangerous than the Delta variant has been detected in more than 30 countries in the past four weeks, says the Health Ministry. "The Lambda strain was [...]
Weakened lungs and immune systems make people increasingly vulnerable, warn scientists. A rash of cases of a rare “black fungus” infection affecting thousands of critically ill Covid patients in India caused alarm last month. [...]